T-wave alternans for risk stratification and prevention of sudden cardiac death

Current Cardiology Reports

Volumn 5, Issue 5, 2003, Pages 350-357

  Pruvot, Etienne J ^a   Rosenbaum, David S ^a  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

CELL POLARITY; CLINICAL PRACTICE; CLINICAL TRIAL; CONGESTIVE CARDIOMYOPATHY; CORONARY ARTERY DISEASE; DEFIBRILLATOR; DIAGNOSTIC VALUE; ELECTROCARDIOGRAPHY; EXERCISE; HEART ARRHYTHMIA; HEART ELECTROPHYSIOLOGY; HEART FAILURE; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART PACING; HEART REPOLARIZATION; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HIGH RISK PATIENT; HUMAN; IMPLANTATION; ISCHEMIC HEART DISEASE; NON INVASIVE MEASUREMENT; POPULATION RESEARCH; PREDICTION; PROGNOSIS; REENTRY ARRHYTHMIA; REVIEW; RISK ASSESSMENT; SCREENING TEST; SUDDEN DEATH; T WAVE; DISEASE COURSE; HEART RATE; INCIDENCE; PATHOPHYSIOLOGY; PHYSIOLOGY; RISK FACTOR; UNITED STATES;

ARRHYTHMIA; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; DISEASE PROGRESSION; ELECTROCARDIOGRAPHY; HEART RATE; HUMANS; INCIDENCE; RISK FACTORS; UNITED STATES;

EID: 0642346182     PISSN: 15233782     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11886-003-0090-4     Document Type: Review

References (42)

1. Myerburg RJ, Kessler KM, Castellanos A: Sudden cardiac death: epidemiology, transient risk, and intervention assessment. Ann Intern Med 1993, 119:1187-1197.
2. Lee TH, Goldman L: The coronary care unit turns 25: historical trends and future directions. Ann Intern Med 1988, 108:887-894.
3. Anonymous: Metoprolol in acute myocardial infarction. Mortality. The MIAMI Trial Research Group. Am J Cardiol 1985, 56:15G-22G.
4. Maggioni AP, Zuanetti G, Franzosi MG, et al.: Prevalence and prognostic significance of ventricular arrhythmias after acute myocardial infarction in the fibrinolytic era. GISSI-2 results. Circulation 1993, 87:312-322.
5. Buxton AE, Lee KL, Fisher JD, et al.: A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators. N Engl J Med 1999, 341:1882-1890.
6. Buxton AE, Lee KL, DiCarlo L, et al.: Electrophysiologic testing to identify patients with coronary artery disease who are at risk for sudden death. Multicenter Unsustained Tachycardia Trial Investigators. N Engl J Med 2000, 342:1937-1945.
7. Moss AJ, Hall WJ, Cannom DS, et al.: Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. N Engl J Med 1996, 335:1933-1940.
8. Moss AJ, Zareba W, Hall WJ, et al.: Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002, 346:877-883.
9. Bigger JT: Expanding indications for implantable cardiac defibrillators. N Engl J Med 2002, 346:931-933.
10. Buxton AE, Lee KL, Hafley GE, et al.: Relation of ejection fraction and inducible ventricular tachycardia to mode of death in patients with coronary artery disease: an analysis of patients enrolled in the multicenter unsustained tachycardia trial. Circulation 2002, 106:2466-2472.
11. Levy D, Kenchaiah S, Larson MG, et al.: Long-term trends in the incidence of and survival with heart failure. N Engl J Med 2002, 347:1397-1402.
12. Risk stratification and survival after myocardial infarction. N Engl J Med 1983, 309:331-336.
13. Rosenbaum DS, Jackson LE, Smith JM, et al.: Electrical alternans and vulnerability to ventricular arrhythmias. N Engl J Med 1994, 330:235-241.
14. Hohnloser SH, Klingenheben T, Li YG, et al.: T wave alternans as a predictor of recurrent ventricular tachyarrhythmias in ICD recipients: prospective comparison with conventional risk markers. J Cardiovasc Electrophysiol 1998, 9:1258-1268.
15. Gold MR, Bloomfield DM, Anderson KP, et al.: A comparison of T-wave alternans, signal averaged electrocardiography and programmed ventricular stimulation for arrhythmia risk stratification. J Am Coll Cardiol 2000, 36:2247-2253.
16. Kitamura H, Ohnishi Y, Okajima K, et al.: Onset heart rate of microvolt-level T-wave alternans provides clinical and prognostic value in nonischemic dilated cardiomyopathy. J Am Coll Cardiol 2002, 39:295-300.
17. Rashba EJ, Osman AF, MacMurdy K, et al.: Exercise is superior to pacing for T wave alternans measurement in subjects with chronic coronary artery disease and left ventricular dysfunction. J Cardiovasc Electrophysiol 2002, 13:845-850.
18. Rashba EJ, Osman AF, MacMurdy K, et al.: influence of QRS duration on the prognostic value of T wave alternans. J Cardiovasc Electrophysiol 2002, 13:770-775.
19. Rashba EJ, Cooklin M, MacMurdy K, et al.: Effects of selective autonomic blockade on T-wave alternans in humans. Circulation 2002, 105:837-842.
20. Herring H: Experimentelle Studien an Saugetieren uber das Electrocardiogramm. Z Exper Med 1909, 7:363.
21. Puletti M, Curione M, Righetti G, et al.: Alternans of the ST segment and T wave in acute myocardial infarction. J Electrocardiol 1980, 13:297-300.
22. Platt SB, Vijgen JM, Albrecht P, et al.: Occult T wave alternans in long QT syndrome. J Cardiovasc Electrophysiol 1996, 7:144-148.
23. Adam DR, Smith JM, Akselrod S, et al.: Fluctuations in T-wave morphology and susceptibility to ventricular fibrillation. J Electrocardiol 1984, 17:209-218.
24. Smith JM, Clancy EA, Valeri CR, et al.: Electrical alternans and cardiac electrical instability. Circulation 1988, 77:110-121.
25. Estes NA3, Michaud G, Zipes DP, et al.: Electrical alternans during rest and exercise as predictors of vulnerability to ventricular arrhythmias. Am J Cardiol 1997, 80:1314-1318.
26. Narayan SM, Smith JM: Differing rate dependence and temporal distribution of repolarization alternans in patients with and without ventricular tachycardia. J Cardiovasc Electrophysiol 1999, 10:61-71.
27. Klingenheben T, Zabel M, D'Agostino RB, et al.: Predictive value of T-wave alternans for arrhythmic events in patients with congestive heart failure. Lancet 2000, 356:651-652.
28. Ikeda T, Sakata T, Takami M, et al.: Combined assessment of T-wave alternans and late potentials used to predict arrhythmic events after myocardial infarction. A prospective study. J Am Coll Cardiol 2000, 35:722-730.
29. Adachi K, Ohnishi Y, Yokoyama M: Risk stratification for sudden cardiac death in dilated cardiomyopathy using microvolt-level T-wave alternans. Jpn Circ J 2001, 65:76-80.
30. Ikeda T, Saito H, Tanno K, et al.: T-wave alternans as a predictor for sudden cardiac death after myocardial infarction. Am J Cardiol 2002, 89:79-82.
31. Klingenheben T, Gronefeld G, Li YG, et al.: Effect of metoprolol and d,l-sotalol on microvolt-level T-wave alternans. Results of a prospective, double-blind, randomized study. J Am Coll Cardiol 2001, 38:2013-2019.
32. Bloomfield DM: T-wave alternans in congestive heart failure. Paper presented at the 52nd annual scientific sessions of the American College of Cardiology. Chicago: March 30-April 3, 2003.
33. Pastore JM, Girouard SD, Laurita KR, et al.: Mechanism linking T-wave alternans to the genesis of cardiac fibrillation. Circulation 1999, 99:1385-1394.
34. Pastore JM, Rosenbaum DS: Role of structural barriers in the mechanism of alternans-induced reentry. Circ Res 2000, 87:1157-1163.
35. Saitoh H, Bailey JC, Surawicz B: Alternans of action potential duration after abrupt shortening of cycle length: differences between dog Purkinje and ventricular muscle fibers. Circ Res 1988, 62:1027-1040.
36. Huser J, Wang YG, Sheehan KA, et al.: Functional coupling between glycolysis and excitation-contraction coupling underlies alternans in cat heart cells. J Physiol 2000, 524:795-806.
37. Kuo CS, Munakata K, Reddy CP, et al.: Characteristics and possible mechanism of ventricular arrhythmia dependent on the dispersion of action potential durations. Circulation 1983, 67:1356-1367.
38. Kavesh NG, Shorofsky SR, Sarang SE, et al.: The effect of procainamide on T wave alternans. J Cardiovasc Electrophysiol 1999, 10:649-654.
39. Tapanainen JM, Still AM, Airaksinen KE, et al.: Prognostic significance of risk stratifiers of mortality, including T wave alternans, after acute myocardial infarction: results of a prospective follow-up study. J Cardiovasc Electrophysiol 2001, 12:645-652.
40. Villella A, Maggioni AP, Villella M, et al.: Prognostic significance of maximal exercise testing after myocardial infarction treated with thrombolytic agents: the GISSI-2 data-base. Gruppo Italiano per lo Studio della Sopravvivenza Nell'Infarto. Lancet 1995, 346:523-529.
41. Hohnloser SH, Klingenheben T, Zabel M, et al.: T wave alternans during exercise and atrial pacing in humans. J Cardiovasc Electrophysiol 1997, 8:987-993.
42. Hohnloser SH, Klingenheben T, Bloomfield D, et al.: Usefulness of T wave alternans for prediction of ventricular tachyarrhythmic events in patients with dilated cardiomyopathy: Results from a prospective observational study. J Am Coll Cardiol 2003, 41:2220-2224.